1. Decadt B, Siriwardena AK. Radiofrequency ablation of liver tumours: systematic review. Lancet Oncol. 2004; 5:550–560. PMID:
15337485.
Article
2. Salhab M, Canelo R. An overview of evidence-based management of hepatocellular carcinoma: a meta-analysis. J Cancer Res Ther. 2011; 7:463–475. PMID:
22269411.
Article
3. Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol. 2012; 107:569–577. quiz 578. PMID:
22158026.
Article
4. Curley SA, Izzo F, Delrio P, Ellis LM, Granchi J, Vallone P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg. 1999; 230:1–8. PMID:
10400029.
5. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology. 2004; 127:1714–1723. PMID:
15578509.
6. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology. 2005; 129:122–130. PMID:
16012942.
Article
7. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology. 2003; 228:235–240. PMID:
12759473.
Article
8. Goldberg SN, Gazelle GS, Solbiati L, Rittman WJ, Mueller PR. Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol. 1996; 3:636–644. PMID:
8796727.
9. Rossi S, Buscarini E, Garbagnati F, Di Stasi M, Quaretti P, Rago M, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol. 1998; 170:1015–1022. PMID:
9530052.
Article
10. Miao Y, Ni Y, Yu J, Zhang H, Baert A, Marchal G. An ex vivo study on radiofrequency tissue ablation: increased lesion size by using an "expandable-wet" electrode. Eur Radiol. 2001; 11:1841–1847. PMID:
11511912.
Article
11. Goldberg SN, Solbiati L, Hahn PF, Cosman E, Conrad JE, Fogle R, et al. Large-volume tissue ablation with radio frequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology. 1998; 209:371–379. PMID:
9807561.
Article
12. Lee JM, Han JK, Lee JY, Kim SH, Choi JY, Lee MW, et al. Hepatic radiofrequency ablation using multiple probes: ex vivo and in vivo comparative studies of monopolar versus multipolar modes. Korean J Radiol. 2006; 7:106–117. PMID:
16799271.
Article
13. Lee JM, Han JK, Kim HC, Choi YH, Kim SH, Choi JY, et al. Switching monopolar radiofrequency ablation technique using multiple, internally cooled electrodes and a multichannel generator: ex vivo and in vivo pilot study. Invest Radiol. 2007; 42:163–171. PMID:
17287646.
14. Lee JM, Han JK, Chang JM, Chung SY, Kim SH, Lee JY, et al. Radiofrequency ablation of the porcine liver in vivo: increased coagulation with an internally cooled perfusion electrode. Acad Radiol. 2006; 13:343–352. PMID:
16488847.
Article
15. Lee ES, Lee JM, Kim WS, Choi SH, Joo I, Kim M, et al. Multiple-electrode radiofrequency ablations using Octopus® electrodes in an in vivo porcine liver model. Br J Radiol. 2012; 85:e609–e615. PMID:
22422385.
16. Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI. Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume. Acad Radiol. 1995; 2:399–404. PMID:
9419582.
17. McGhana JP, Dodd GD 3rd. Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol. 2001; 176:3–16. PMID:
11133529.
18. Rhim H. Complications of radiofrequency ablation in hepatocellular carcinoma. Abdom Imaging. 2005; 30:409–418. PMID:
15688113.
Article
19. Lubienski A, Bitsch RG, Lubienski K, Kauffmann G, Duex M. Radiofrequency ablation (RFA): development of a flow model for bovine livers for extensive bench testing. Cardiovasc Intervent Radiol. 2006; 29:1068–1072. PMID:
16845558.
Article
20. Kim SW, Rhim H, Park M, Kim H, Kim YS, Choi D, et al. Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy. Korean J Radiol. 2009; 10:366–376. PMID:
19568465.
Article
21. Seong NJ, Yoon CJ, Kang SG, Chung JW, Kim HC, Park JH. Effects of arsenic trioxide on radiofrequency ablation of VX2 liver tumor: intraarterial versus intravenous administration. Korean J Radiol. 2012; 13:195–201. PMID:
22438687.
Article
22. Lee J, Lee JM, Yoon JH, Lee JY, Kim SH, Lee JE, et al. Percutaneous radiofrequency ablation with multiple electrodes for medium-sized hepatocellular carcinomas. Korean J Radiol. 2012; 13:34–43. PMID:
22247634.
Article